Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in ...

Patients with bronchiectasis and a Pseudomonas aeruginosa infection receiving gremubamab, a bispecific monoclonal antibody, ...

The CDC's Advisory Committee on Immunization Practices voted to ban thimerosal, a harmless preservative, in what critics say ...

Celiac Disease Market Insight, Epidemiology And Market ForecastThe celiac disease treatment market is experiencing significant expansion, dr ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

New research analyzed brain imaging information with clinical evaluation to derive six brain-based psychopathology dimensions ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

Condon explained the cows have their own legacy within the records of the camp. In a report filed by superintendent Willard ...

Daratumumab effectively delays multiple myeloma relapse by monitoring minimal residual disease, offering hope for improved ...

Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 ...

These activities are further supported by the in-vivo data demonstrating that both the NKG2A and CD3 arms contribute to the ...